NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/04/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization30.71 mln
Float55.09 mln
Earnings Date08/04/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.31
Reliable
1-Year Forecast
2.88
Transformational upside
Relative Strength
72
/ 100
Outperforming
Debt / Equity
13.34
Extremely leveraged
ROE
-137
Deeply negative
Business Description
Founded in 1997 and based in Princeton, New Jersey, Cytosorbents Corporation develops and sells medical devices built around a specialized polymer technology that filters harmful substances from the blood. Its best-known product, CytoSorb, is used in hospital settings to treat serious conditions such as sepsis, organ failure, and complications arising from heart surgery. The company also offers a range of related products targeting drug removal, veterinary care, organ preservation, and blood compatibility, serving customers across the United States, Germany, and other international markets.
